These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 38364356)

  • 1. Evaluating the implementation of a prescription only regulatory model for nicotine vaping products: A qualitative study on the experiences and views of healthcare professionals.
    Morphett K; Holland A; Ward S; Steadman KJ; Zwar NA; Gartner C
    Int J Drug Policy; 2024 Mar; 125():104353. PubMed ID: 38364356
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discussions between health professionals and smokers about nicotine vaping products: results from the 2016 ITC Four Country Smoking and Vaping Survey.
    Gravely S; Thrasher JF; Cummings KM; Ouimet J; McNeill A; Meng G; Lindblom EN; Loewen R; O'Connor RJ; Thompson ME; Hitchman SC; Hammond D; Heckman BW; Borland R; Yong HH; Elton-Marshall T; Bansal-Travers M; Gartner C; Fong GT
    Addiction; 2019 Oct; 114 Suppl 1(Suppl 1):71-85. PubMed ID: 30548374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Self-Reported Quit Aids and Assistance Used By Smokers At Their Most Recent Quit Attempt: Findings from the 2020 International Tobacco Control Four Country Smoking and Vaping Survey.
    Gravely S; Cummings KM; Hammond D; Borland R; McNeill A; East KA; Loewen R; Martin N; Yong HH; Li L; Liber A; Levy DT; Quah ACK; Ouimet J; Hitchman SC; Thompson ME; Boudreau C; Fong GT
    Nicotine Tob Res; 2021 Aug; 23(10):1699-1707. PubMed ID: 33837435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adult smokers' discussions about vaping with health professionals and subsequent behavior change: a cohort study.
    Cho YJ; Thrasher JF; Gravely S; Alberg A; Borland R; Yong HH; Cummings KM; Hitchman SC; Fong GT
    Addiction; 2022 Nov; 117(11):2933-2942. PubMed ID: 35792058
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nicotine vaping products as a harm reduction tool among smokers: Review of evidence and implications for pharmacy practice.
    Erku D; Gartner CE; Morphett K; Snoswell CL; Steadman KJ
    Res Social Adm Pharm; 2020 Sep; 16(9):1272-1278. PubMed ID: 32061550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Do Smokers' Perceptions of the Harmfulness of Nicotine Replacement Therapy and Nicotine Vaping Products as Compared to Cigarettes Influence Their Use as an Aid for Smoking Cessation? Findings from the ITC Four Country Smoking and Vaping Surveys.
    Yong HH; Gravely S; Borland R; Gartner C; Michael Cummings K; East K; Tagliaferri S; Elton-Marshall T; Hyland A; Bansal-Travers M; Fong GT
    Nicotine Tob Res; 2022 Aug; 24(9):1413-1421. PubMed ID: 35368082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nicotine vaping product use, harm perception and policy support among pharmacy customers in Brisbane, Australia.
    Erku DA; Gartner CE; Tengphakwaen U; Morphett K; Steadman KJ
    Drug Alcohol Rev; 2019 Sep; 38(6):703-711. PubMed ID: 31486151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Associations Between Noticing Nicotine Vaping Product Health Warning Labels, Harm Perceptions, and Use Among Adult Vapers, Current and Former Smokers. Findings From the 2018 ITC Four Country Smoking and Vaping Survey.
    Taylor E; Aleyan S; East K; Michael Cummings K; Thrasher JF; Fong GT; Quah ACK; Li G; Borland R; Hammond D; Hitchman SC
    Nicotine Tob Res; 2022 Jun; 24(7):1020-1027. PubMed ID: 34893915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Do Australians use the prescription pathway when using nicotine vaping products to quit smoking?
    Borland R; Le Grande M; Gartner C; Morphett K
    Int J Drug Policy; 2024 Jun; 128():104460. PubMed ID: 38776582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of anxiety and depression symptoms with perceived health risk of nicotine vaping products for smoking cessation.
    Trigg J; Calabro R; Anastassiadis P; Bowden J; Bonevski B
    Front Psychiatry; 2024; 15():1277781. PubMed ID: 38487571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Views and preferences of people living with HIV about smoking, quitting and use of nicotine products.
    Edwards S; Fitzgerald L; Mutch A; Dean JA; Ford P; Howard C; Watts P; Gartner C
    Int J Drug Policy; 2021 Nov; 97():103349. PubMed ID: 34252787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Do Social Norms for Cigarette Smoking and Nicotine Vaping Product Use Predict Trying Nicotine Vaping Products and Attempts to Quit Cigarette Smoking Amongst Adult Smokers? Findings From the 2016-2020 International Tobacco Control Four Country Smoking and Vaping Surveys.
    Yong HH; Chow R; East K; Thrasher JF; Hitchman SC; Borland R; Cummings KM; Fong GT
    Nicotine Tob Res; 2023 Feb; 25(3):505-513. PubMed ID: 36082962
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of awareness, ever-use and current use of nicotine vaping products (NVPs) among adult current smokers and ex-smokers in 14 countries with differing regulations on sales and marketing of NVPs: cross-sectional findings from the ITC Project.
    Gravely S; Driezen P; Ouimet J; Quah ACK; Cummings KM; Thompson ME; Boudreau C; Hammond D; McNeill A; Borland R; Thrasher JF; Edwards R; Omar M; Hitchman SC; Yong HH; Barrientos-Gutierrez T; Willemsen MC; Bianco E; Boado M; Goma FM; Seo HG; Nargis N; Jiang Y; Perez CA; Fong GT
    Addiction; 2019 Jun; 114(6):1060-1073. PubMed ID: 30681215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Australia Smoking and Vaping Model: The Potential Impact of Increasing Access to Nicotine Vaping Products.
    Levy DT; Gartner C; Liber AC; Sánchez-Romero LM; Yuan Z; Li Y; Cummings KM; Borland R
    Nicotine Tob Res; 2023 Feb; 25(3):486-497. PubMed ID: 36073731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Framing and scientific uncertainty in nicotine vaping product regulation: An examination of competing narratives among health and medical organisations in the UK, Australia and New Zealand.
    Erku DA; Kisely S; Morphett K; Steadman KJ; Gartner CE
    Int J Drug Policy; 2020 Apr; 78():102699. PubMed ID: 32086156
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differences in norms towards the use of nicotine vaping products among adult smokers, former smokers and nicotine vaping product users: cross-sectional findings from the 2016 ITC Four Country Smoking and Vaping Survey.
    Aleyan S; East K; McNeill A; Cummings KM; Fong GT; Yong HH; Thrasher JF; Borland R; Hitchman SC
    Addiction; 2019 Oct; 114 Suppl 1(Suppl 1):97-106. PubMed ID: 31062388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perceptions of nicotine vaping products among Australians living with HIV.
    Edwards S; Puljević C; Dean JA; Gilks C; Boyd MA; Watts P; Howard C; Gartner CE
    AIDS Care; 2024 Dec; 36(12):1760-1770. PubMed ID: 39102745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How are nicotine vaping products represented to pharmacists? A content analysis of Australian pharmacy news sources.
    Erku DA; Zhang R; Gartner CE; Morphett K; Steadman KJ
    Int J Pharm Pract; 2020 Aug; 28(4):390-394. PubMed ID: 32311165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Attitudes towards a hypothetical 'clean nicotine' product and harm reduction among smokers.
    Morphett K; Puljević C; Borland R; Carter A; Hall W; Gartner C
    Int J Drug Policy; 2021 Feb; 88():103020. PubMed ID: 33161296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors influencing the uptake and use of nicotine replacement therapy and e-cigarettes in pregnant women who smoke: a qualitative evidence synthesis.
    Campbell K; Coleman-Haynes T; Bowker K; Cooper SE; Connelly S; Coleman T
    Cochrane Database Syst Rev; 2020 May; 5(5):CD013629. PubMed ID: 32441810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.